NCT03492229

Brief Summary

Over four million stroke survivors currently living in the United States are unable to walk independently in the community. To increase the effectiveness of gait rehabilitation, it is critical to develop therapies that are based on an understanding of brain adaptations that occur after stroke. This project will be the first step towards the development of a novel therapeutic approach using brain stimulation to increase walking capacity in stroke survivors and understand the neural mechanisms that are associated with impairment and functional recovery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jan 2014

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
4.2 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 10, 2018

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2020

Completed
Last Updated

August 29, 2022

Status Verified

August 1, 2022

Enrollment Period

5.8 years

First QC Date

March 9, 2018

Last Update Submit

August 25, 2022

Conditions

Keywords

GaitBrain stimulationtDCSWalking

Outcome Measures

Primary Outcomes (1)

  • Change in gait speed using 10 meter walk test

    10-meter walk test: Gait speed will be measured as the average of 3 trials of the 10-m walk test. Participants will be asked to walk at their normal comfortable pace to cover a distance of 10 meters without an AFO (handheld assistive device is acceptable if needed).

    Change from baseline to immediately after training and baseline to 3 months follow up

Secondary Outcomes (4)

  • Change in 6 minute walk test

    Change from baseline to immediately after training and baseline to 3 months follow up

  • Change in Berg Balance Scale

    Change from baseline to immediately after training and baseline to 3 months follow up

  • Change in Quality of life measures

    Change from baseline to immediately after training and baseline to 3 months follow up

  • Change in cortical excitability of leg muscles using TMS

    Change from baseline to immediately after training and baseline to 3 months follow up

Study Arms (4)

tDCS+AMT

EXPERIMENTAL

TDCS in combination with movement training before treadmill training

Other: tDCSOther: AMTBehavioral: Treadmill training

tDCS

ACTIVE COMPARATOR

tDCS only before treadmill training

Other: tDCSBehavioral: Treadmill training

AMT

ACTIVE COMPARATOR

Movement training only before treadmill training

Other: AMTBehavioral: Treadmill training

Control

SHAM COMPARATOR

No priming before treadmill training

Behavioral: Treadmill training

Interventions

tDCSOTHER

1 mA of tDCS

tDCStDCS+AMT
AMTOTHER

Ankle motor training

AMTtDCS+AMT

High intensity treadmill training

AMTControltDCStDCS+AMT

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 50 - 80 years
  • First ever monohemispheric stroke \> 6 months since onset
  • Residual hemiparetic gait deficits
  • Able to walk without an ankle orthotic for 5 minutes at self-paced speed. Handheld assistive device is acceptable.

You may not qualify if:

  • Severe osteoporosis
  • Contracture-limiting range of motion of lower limb
  • Uncontrolled anti-spasticity medications during the study period
  • Cardiorespiratory or metabolic diseases (e.g. cardiac arrhythmia, uncontrolled hypertension or diabetes, chronic emphysema)
  • Unhealed decubiti, persistent infection
  • Significant cognitive or communication impairment (MMSE \<21), which could impede the understanding of the purpose of procedures of the study or prevent the patient from performing the tracking task.
  • Lesions pertaining to the brainstem and cerebellum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Illinois at Chicago

Chicago, Illinois, 60612-7246, United States

Location

Related Publications (1)

  • Madhavan S, Cleland BT, Sivaramakrishnan A, Freels S, Lim H, Testai FD, Corcos DM. Cortical priming strategies for gait training after stroke: a controlled, stratified trial. J Neuroeng Rehabil. 2020 Aug 17;17(1):111. doi: 10.1186/s12984-020-00744-9.

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Sangeetha Madhavan

    UIC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 9, 2018

First Posted

April 10, 2018

Study Start

January 1, 2014

Primary Completion

October 31, 2019

Study Completion

August 15, 2020

Last Updated

August 29, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations